WHAT IS THE REAL COST OF DELAYING AN IPF DIAGNOSIS?

This content is intended for healthcare professionals.
IPF - idiopathic pulmonary fibrosis
From the time of diagnosis, the median estimated survival time is 2-5 years2
This content is sponsored by Boehringer Ingelheim UK.
  • The most common idiopathic interstitial pneumonia is idiopathic pulmonary fibrosis (IPF)4 IPF is a chronic, progressive, fibrotic interstitial lung disease of unknown cause, often with characteristic imaging and histologic appearances.4 It is characterised by worsening breathlessness and progressive loss of lung function.4
  • IPF occurs primarily in older adults, and is more common in men than women5 IPF is a rare disease but is estimated to affect approximately 32,500 people in the UK with approximately 6,000 new cases diagnosed per/year.6
  • Delays in referring patients with suspected IPF can reduce survival7 Diagnostic delay in IPF is estimated to be 1.5 to >3 years.8,9
    From the time of diagnosis, the median estimated survival time is 2-5 years.2
  • Refer patients for diagnosis immediately when you suspect IPF.

    Click here to see how to identify suspected IPF patients